The California Institute for Regenerative Medicine (CIRM) and the Chinese Ministry of Science and Technology (MOST) have agreed to collaborate on stem cell research. The agreement will make it easier to form cross-border teams that are working in similar areas. If the teams’ funding requests are approved, the researchers in each country will be supported by their respective agency, CIRM or MOST. The formal announcement, made today, adds details to a story that ChinaBio® Today originally broke late last week (…)
“Our collaboration will benefit patients in our countries and patients around the globe,” said Wan Gang, Minister, MOST. “We
BRITISH face surgeons are to grow new skull, cheek and jaw bones on patients’ backs using their own stem cells.
The surgeons, from Barts and the London NHS Trust, hope to use the technique to help people whose facial bones have been destroyed by cancer or injury.
Four patients are awaiting the treatment, which the surgeons believe could eventually become a less risky alternative to face transplants. Two are cancer victims and two have had accidents.
The team, led by Iain Hutchison, will make the first attempt to grow replacement bone from a patient’s own stem cells in Britain.
The procedure involves constructing
TUCSON (KGUN9-TV) – More than 30 million Americans suffer from painful arthritis in their joints, Osteoarthritis. The most common problem is knee pain caused by cartilage breaking down. But some remarkable findings at the UA Arthritis Center could change the way doctors treat these patients.
Since our knees carry most of our body weight, it’s no surprise that the joints can wear out. Too much wear-and-tear on the cartilage covering the bone can cause serious knee pain. Right now, the only solution is replacing the entire joint with metal and plastic parts, even if the damage is just in one
The latest developments in molecular biology in the prenatal diagnostic field, particularly regarding preserving stem cells extracted from amniotic liquid, were the focus of the latest S.I.Di.P conference (Italian Society of Prenatal Diagnosis and Maternal Fetal Medicine).
After a greeting from S.I.Di.P President Claudio Giorlandino and President of the Italian Gynecology and Obstetrics Society Giorgio Vittori, Professor Giuseppe Simone, the head of the Biocell Center in Busto Arsizio (VA), the first Italian center able to treat and store stem cells extracted from the amniotic liquid in liquid nitrogen, opened the conference.
“In the next five to ten years,” explained Professor Simoni,
In a landmark paper, researchers at Stanford University have described a new way to derive human induced pluripotent stem cells (iPSCs) without the use of contaminating mouse feeder cells. Using adipose cells as the starting cell population and mTeSR1, a defined medium that allows the expansion of human embryonic and induced pluripotent stem cells without the use of feeders, the researchers were able to fully reprogram the cells to the pluripotent state.
mTeSR1 is a fully defined medium and is the most widely used feeder-independent method for culturing human pluripotent stem cells, with citations in more than 25 publications.